Most Dana D - OmicsDI

Show results for

Unknown (1071)
Transcriptomics (61)
Proteomics (29)
Genomics (15)
Genomic (4)
Metabolomics (4)
Models (1)

Organisms

Homo sapiens (43)
Mus musculus (19)
Saccharomyces cerevisiae (10)
Arabidopsis thaliana (4)
Rattus norvegicus (3)
Escherichia coli (3)
Fusarium fujikuroi (1)
Penicillium chrysogenum (1)
Acanthamoeba polyphaga mimivirus (1)
Cucumis sativus (1)
Brassica rapa (1)
Bacillus amyloliquefaciens (1)
Medicago truncatula (1)
Zea mays (1)
Schizosaccharomyces pombe (1)
Salmonella enterica subsp. enterica serovar Typhimurium (1)
Bos taurus (1)
Glycine max (1)
Oryza sativa Japonica Group (1)
Triticum aestivum (1)
Vipera anatolica senliki (1)
Klebsiella pneumoniae (1)
Klebsiella variicola (1)
Staphylococcus aureus (1)
Streptococcus pyogenes (1)
Trypanosoma brucei (1)

Repository

biostudies-arrayexpress (62)
pride (21)
EGA (14)
dbGaP (4)
MassIVE (4)
MetaboLights (4)
PAXDB (2)
BioModels (1)
jPOST (1)
PanoramaPublic (1)

Tissue

Cell culture (8)
Permanent cell line cell (4)
Brown adipose tissue (2)
B cell (1)
Early embryonic cell (1)
Embryo (1)
Epithelial cell (1)
Lymph node (1)
Primary neuron (1)
Skeletal muscle (1)
Urine (1)

Disease

Locally advanced rectal cancer (1)
Acute leukemia (1)
Parkinson's disease (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (21)
Shotgun proteomics (13)
SWATH MS (6)
Mass spectrometry (3)
Illumina HiSeq 2000 (2)
SRM/MRM (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Illumina OMNIExpress, Affymetrix_6.0, HanChinese_Immunochip (1)
Mass spectrometry assay (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)

Instrument Platform

Liquid Chromatography MS - alternating - hilic (2)
Liquid Chromatography MS - negative - hilic (2)
Liquid Chromatography MS - positive - hilic (2)
Aspara® Smart Grower Hydroponic (1)
HiSeq 2000 (1)
NovaSeq PE150 (1)
Spectrum™ Plant Total RNA Kit (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 2000 (1)
LTQ Orbitrap XL (1)
MALDI Synapt G2-S HDMS (1)
Q Exactive Plus (1)
TripleTOF 6600 (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2015 (10)
2013 (10)
2008 (9)
2014 (8)
2010 (7)
2022 (7)
2021 (7)
2016 (6)
2020 (5)
2024 (4)
2012 (4)
2009 (4)
2025 (4)
2011 (3)
2007 (2)
2023 (2)
2004 (1)
2019 (1)
2026 (1)
2018 (1)

UNIPROT ID/AC

14331_ORYSJ (2)
14332_ORYSJ (2)
14333_ORYSJ (2)
14334_ORYSJ (2)
14335_ORYSJ (2)
14336_ORYSJ (2)
2ABA_ORYSJ (2)
40G2_ORYSJ (2)
6PGD1_ORYSJ (2)
6PGD2_ORYSJ (2)
6PGL4_ORYSJ (2)
A0A024FLK4_ORYSJ (2)
A0A0N7KDM0_ORYSJ (2)
A0A0N7KG12_ORYSJ (2)
A0A0N7KGX7_ORYSJ (2)
A0A0N7KH16_ORYSJ (2)
A0A0N7KIK0_ORYSJ (2)
A0A0N7KJV4_ORYSJ (2)
A0A0N7KKI1_ORYSJ (2)
A0A0P0V093_ORYSJ (2)
A0A0P0V197_ORYSJ (2)
A0A0P0V1X3_ORYSJ (2)
A0A0P0V4P0_ORYSJ (2)
A0A0P0V7A3_ORYSJ (2)
A0A0P0V994_ORYSJ (2)
A0A0P0VEP5_ORYSJ (2)
A0A0P0VH79_ORYSJ (2)
A0A0P0VLJ4_ORYSJ (2)
A0A0P0VNU0_ORYSJ (2)
A0A0P0VQM8_ORYSJ (2)

CHEBI ID

CHEBI:15356 (1)
CHEBI:15428 (1)
CHEBI:15741 (1)
CHEBI:16108 (1)
CHEBI:16119 (1)
CHEBI:16199 (1)
CHEBI:16235 (1)
CHEBI:16335 (1)
CHEBI:16449 (1)
CHEBI:16634 (1)
CHEBI:16708 (1)
CHEBI:16737 (1)
CHEBI:16856 (1)
CHEBI:16865 (1)
CHEBI:17234 (1)
CHEBI:17306 (1)
CHEBI:17345 (1)
CHEBI:17797 (1)
CHEBI:17822 (1)
CHEBI:17858 (1)
CHEBI:17992 (1)
CHEBI:18012 (1)
CHEBI:18186 (1)
CHEBI:18211 (1)
CHEBI:18222 (1)
CHEBI:18237 (1)
CHEBI:18257 (1)
CHEBI:22653 (1)
CHEBI:22660 (1)
CHEBI:229948 (1)

Metabolite Name

Citric acid (2)
Fructose (2)
Ornithine (2)
Pyruvic acid (2)
Raffinose (2)
Succinic acid (2)
(+/-)9-HpODE (1)
(-)-3-dehydroshikimic acid (1)
(-)-Epigallocatechin Gallate (1)
(R)-3-Hydroxy myristic acid (1)
1,2,3,6-tetragalloylglucose (1)
1-(9Z,12Z-Octadecadienoyl)-2-hydroxy-sn-glycero-3-phosphoethanolamine (1)
1-O-Sinapoyl-beta-D-glucose (1)
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (1)
2,5-Furandicarboxylic acid (1)
2-Hydroxypalmitic Acid (1)
2-Isopropylmalic acid (1)
2-Methylcitric acid (1)
2-Oxoglutaric acid (1)
2-oxoglutaric acid (1)
3,5-Dihydroxy-4-methoxybenzoic acid (1)
3,5-dihydroxybenzoic acid (1)
3-Hydroxydecanoic acid (1)
3-[(Carboxycarbonyl)amino]-L-alanine (1)
3-hydroxyhexadecanoic acid (1)
4-Dodecylbenzenesulfonic acid (1)
5-Methoxypsoralen (1)
9-HODE (1)
Aceglutamide (1)
Acetylsalvipisone (1)

IsPrivate

False (1)

Model Flag

Non Kinetic (1)

Modelling Approach

Constraint-based model (1)

Study type

Transcription profiling by array (45)
Comparative genomic hybridization by array (5)
RNA-seq of coding RNA (4)
Unknown experiment type (3)
Other (2)
ChIP-seq (1)
Methylation profiling by array (1)
RNA-seq of non coding RNA (1)

Release Date

2022 (112)
2021 (97)
2025 (92)
2023 (89)
2020 (88)
2024 (83)
2019 (77)
2017 (65)
2016 (63)
2018 (58)
2014 (57)
2015 (56)
2012 (40)
2013 (36)
2010 (28)
2011 (19)
2009 (19)
2008 (13)
2007 (12)
2026 (10)
2006 (9)
2005 (3)
2001 (3)
2002 (2)
2004 (1)
1999 (1)

Lab affiliation

Bioplatforms Australia (4)
Dept. of Biological Chemistry,The Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem,Givat Ram Campus, Jerusalem, 91904, Israel (2)
Associate Professor, Vice president of the ISBMB society The Center for Nanoscience and Nanotechnology The Alexander Silberman Institute of Life Science Dept. of Biological Chemistry, room 1-637 The Hebrew University of Jerusalem Givat Ram Campus, Jerusalem, 9190401, Israel (1)
Dana Farber Assistant Professor (1)
Dana Farber Cancer Institute, Boston, MA Harvard Medical School, Boston, MA (1)
Dana-Farber Cancer Institute and Harvard Medical School (1)
Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215 (1)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (1)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Cell Biology, Harvard Medical School, Boston, MA, USA. (1)
Department of Pathology, Dana-Farber/Harvard Cancer Center, Harvard Medical School; Department of Laboratory Medicine, Boston Children's Hospital, Enders Research Building, Room 811, Boston, MA, 02115, USA. (1)
Dept. of Biological Chemistry The Alexander Silberman Institute of Life Science The Hebrew University of Jerusalem (1)
Dept. of Biological Chemistry, room 1-637 The Alexander Silberman Institute of Life Science The Hebrew University of Jerusalem (1)
Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA Department of Radiation Oncology, Brigham and Women’s Hospital, Boston, MA 02115 (1)
School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650 (1)
School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650,Australia (1)
The Rockefeller University Center for Clinical and Translational Science, New York NY (1)
dana farber cancer institute and harvard medical school (1)

Previous page
1 / 119
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 119
Next page

Sort by:

Relevance

Page size

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors (SNP array)

The clinical efficacy of EGFR kinase inhibitors is limited by the development of drug resistance. The irreversible EGFR kinase inhibitor WZ4002 is effective against the most common mechanism of drug resistance mediated by the EGFR T790M mutation. Here we show that in multiple complementary models ha...

ORGANISM(S): Homo sapiens

2012-10-01 | E-GEOD-37698 | biostudies-arrayexpress

Expression data from liver, PFC and amygdala of mice treated with PPAR agonists

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that act as ligand-activated transcription factors. Although prescribed for dyslipidemia and type-II diabetes, PPAR agonists have demonstrated therapeutic properties for several brain disorders, including alcohol depen...

ORGANISM(S): Mus musculus

2015-04-14 | E-GEOD-67796 | biostudies-arrayexpress

Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.

Not available

S-EPMC5012662 | biostudies-literature

Expression data from wild-type and HMGN1 knockout mice injected with N-nitrosodiethylamine

HMGN1 contributes to the shortened latency of liver tumorigenesis by changing a chromatin structure and expression of relevant genes To assess the molecular mechanisms underlying accelerated tumor development in Hmgn1-/- mice, we performed the gene expression profiling of liver cells at early stages...

ORGANISM(S): Mus musculus

2013-08-24 | E-GEOD-44356 | biostudies-arrayexpress

Transcription profiling of human mononuclear cells from acute megakaryoblastic leukemia with and without Down syndrome

mononuclear cells were isolated on a density gradient and RNA extracted using Trizol and the Promega SV column RNA purification. Affymetrix U133A chips were hybridised using standard procedures at the core facility of Dana Farber Cancer Institute. Experiment Overall Design: This series includes samp...

ORGANISM(S): Homo sapiens

2008-06-12 | E-GEOD-4119 | biostudies-arrayexpress

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.

Not available

S-EPMC5658456 | biostudies-literature

Smallholder Broiler Farmers' Characteristics to Uptake Measures Against Highly Pathogenic Avian Influenza in Western Java.

Not available

S-EPMC8883136 | biostudies-literature

Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study.

Not available

S-EPMC9509057 | biostudies-literature

Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.